Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Vtx-002
2. 2097854-81-2
3. Vtx002
4. Opl-002
5. K02shw3kv9
6. Refchem:1099390
7. (5r)-5-[2,5-dichloro-4-[5-[8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4-oxadiazol-3-yl]phenoxy]piperidin-2-one
8. Tamuzimod [inn]
9. Tamuzimod (usan/inn)
10. Tamuzimod [usan]
11. Orb1982659
12. Chembl5314488
13. Schembl18869627
14. Schembl30275258
15. Hnrwgydmtrplcq-snvbaglbsa-n
16. Glxc-27924
17. Da-78185
18. Hy-148801
19. Cs-0641186
20. D12897
21. (5r)-5-(2,5-dichloro-4-{5-[8-chloro-6- (trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4- Oxadiazol-3-yl}phenoxy)piperidin-2-one
22. 2-piperidinone, 5-[2,5-dichloro-4-[5-[8-chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]-1,2,4-oxadiazol-3-yl]phenoxy]-
| Molecular Weight | 546.7 g/mol |
|---|---|
| Molecular Formula | C21H13Cl3F3N5O3 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 94.6 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 786 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
77
PharmaCompass offers a list of Tamuzimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tamuzimod manufacturer or Tamuzimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tamuzimod manufacturer or Tamuzimod supplier.
A Tamuzimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamuzimod, including repackagers and relabelers. The FDA regulates Tamuzimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamuzimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tamuzimod supplier is an individual or a company that provides Tamuzimod active pharmaceutical ingredient (API) or Tamuzimod finished formulations upon request. The Tamuzimod suppliers may include Tamuzimod API manufacturers, exporters, distributors and traders.
Tamuzimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tamuzimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tamuzimod GMP manufacturer or Tamuzimod GMP API supplier for your needs.
A Tamuzimod CoA (Certificate of Analysis) is a formal document that attests to Tamuzimod's compliance with Tamuzimod specifications and serves as a tool for batch-level quality control.
Tamuzimod CoA mostly includes findings from lab analyses of a specific batch. For each Tamuzimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tamuzimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Tamuzimod EP), Tamuzimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tamuzimod USP).
